Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2013
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
Christophe J Desmet, Tristan Gallenne, Alexandre Prieur, et al.
Nature Communications
|
December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Cell Reports. Medicine
|
June 10, 2022
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
Zhengkui Zhang, Xiangjun Kong, Maarten A Ligtenberg, et al.
Pigment Cell & Melanoma Research
|
December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib
Marlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Plos One
|
May 25, 2019
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer
Willemijn S M E Theelen, Thomas Kuilman, Katja Schulze, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 11, 2017
Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance
Julia M Houthuijzen, Ilse Oosterom, Brian D Hudson, et al.
Cancer Research
|
February 3, 2021
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade
Julia Boshuizen, Nora Pencheva, Oscar Krijgsman, et al.
Nature Cell Biology
|
June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities
Jean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Nature Communications
|
April 9, 2022
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
Georgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman, et al.
Nature Communications
|
August 10, 2020
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2013
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
Christophe J Desmet, Tristan Gallenne, Alexandre Prieur, et al.
Nature Communications
|
December 16, 2014
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, et al.
Cell Reports. Medicine
|
June 10, 2022
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
Zhengkui Zhang, Xiangjun Kong, Maarten A Ligtenberg, et al.
Pigment Cell & Melanoma Research
|
December 18, 2014
Detailed imaging and genetic analysis reveal a secondary BRAF(L505H) resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib
Marlous Hoogstraat, Christa G Gadellaa-van Hooijdonk, Inge Ubink, et al.
Plos One
|
May 25, 2019
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer
Willemijn S M E Theelen, Thomas Kuilman, Katja Schulze, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 11, 2017
Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance
Julia M Houthuijzen, Ilse Oosterom, Brian D Hudson, et al.
Cancer Research
|
February 3, 2021
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade
Julia Boshuizen, Nora Pencheva, Oscar Krijgsman, et al.
Nature Cell Biology
|
June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities
Jean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Nature Communications
|
April 9, 2022
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
Georgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman, et al.
Nature Communications
|
August 10, 2020
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman, et al.
Page
of 12